Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (1-10 of 339) with videos related to

Pageof 34
Sort By:
Endocrine-Related Cancer|September 7, 2006
Pure oestrogen antagonists for the treatment of advanced breast cancerAnthony Howell
Women'S Health (London, England)|October 7, 2009
Anastrozole: a new gold standard of hormonal treatment for breast cancer?Anthony Howell
Clinical Chemistry|February 16, 2012
Genesis and outcome of a breast cancer trial to develop the aromatase inhibitor anastrozoleAnthony Howell
Cancer Treatment Reviews|October 4, 2005
The future of fulvestrant ("Faslodex")Anthony Howell
Trends in Endocrinology and Metabolism: TEM|October 11, 2005
New developments in the treatment of postmenopausal breast cancerAnthony Howell
Breast Cancer Research : BCR|December 22, 2010
The emerging breast cancer epidemic: early diagnosis and treatmentAnthony Howell
Lancet (London, England)|August 9, 2005
Adjuvant aromatase inhibitors for breast cancerAnthony Howell
European Journal of Cancer (Oxford, England : 1990)|November 1, 2002
Selective oestrogen receptor downregulatorAnthony Howell
Breast Cancer Research : BCR|November 13, 2004
An early peak of relapse after surgery for breast cancerAnthony Howell
Current Opinion in Obstetrics & Gynecology|June 25, 2005
Selective oestrogen receptor modulators, aromatase inhibitors and the female breastAnthony Howell
Pageof 34

Showing results (1-10 of 339) with videos related to

Sort By:
Pageof 34
Endocrine-Related Cancer|September 7, 2006
Pure oestrogen antagonists for the treatment of advanced breast cancerAnthony Howell
Women'S Health (London, England)|October 7, 2009
Anastrozole: a new gold standard of hormonal treatment for breast cancer?Anthony Howell
Clinical Chemistry|February 16, 2012
Genesis and outcome of a breast cancer trial to develop the aromatase inhibitor anastrozoleAnthony Howell
Cancer Treatment Reviews|October 4, 2005
The future of fulvestrant ("Faslodex")Anthony Howell
Trends in Endocrinology and Metabolism: TEM|October 11, 2005
New developments in the treatment of postmenopausal breast cancerAnthony Howell
Breast Cancer Research : BCR|December 22, 2010
The emerging breast cancer epidemic: early diagnosis and treatmentAnthony Howell
Lancet (London, England)|August 9, 2005
Adjuvant aromatase inhibitors for breast cancerAnthony Howell
European Journal of Cancer (Oxford, England : 1990)|November 1, 2002
Selective oestrogen receptor downregulatorAnthony Howell
Breast Cancer Research : BCR|November 13, 2004
An early peak of relapse after surgery for breast cancerAnthony Howell
Current Opinion in Obstetrics & Gynecology|June 25, 2005
Selective oestrogen receptor modulators, aromatase inhibitors and the female breastAnthony Howell
Pageof 34